DE10299039I1 - Antivirale Pyrimidin- und Purinverbindungen Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Praeparte - Google Patents
Antivirale Pyrimidin- und Purinverbindungen Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische PraeparteInfo
- Publication number
- DE10299039I1 DE10299039I1 DE2002199039 DE10299039C DE10299039I1 DE 10299039 I1 DE10299039 I1 DE 10299039I1 DE 2002199039 DE2002199039 DE 2002199039 DE 10299039 C DE10299039 C DE 10299039C DE 10299039 I1 DE10299039 I1 DE 10299039I1
- Authority
- DE
- Germany
- Prior art keywords
- preparation
- pharmaceutical preparations
- preparations containing
- purine compounds
- compounds process
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888829571A GB8829571D0 (en) | 1988-12-19 | 1988-12-19 | Antiviral compounds |
GB898905159A GB8905159D0 (en) | 1989-03-07 | 1989-03-07 | Antiviral compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DE10299039I1 true DE10299039I1 (de) | 2003-02-20 |
Family
ID=26294743
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2002199039 Pending DE10299039I1 (de) | 1988-12-19 | 1989-12-18 | Antivirale Pyrimidin- und Purinverbindungen Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Praeparte |
DE68922903T Expired - Lifetime DE68922903T2 (de) | 1988-12-19 | 1989-12-18 | Antivirale Pyrimidin- und Purinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68922903T Expired - Lifetime DE68922903T2 (de) | 1988-12-19 | 1989-12-18 | Antivirale Pyrimidin- und Purinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5043339A (de) |
EP (1) | EP0375329B1 (de) |
JP (1) | JP2788084B2 (de) |
AT (1) | ATE123285T1 (de) |
AU (1) | AU618436B2 (de) |
CA (1) | CA2005815C (de) |
CY (1) | CY2058B1 (de) |
DE (2) | DE10299039I1 (de) |
HK (1) | HK1000142A1 (de) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458772B1 (en) | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
USRE37979E1 (en) * | 1989-09-29 | 2003-02-04 | Mitsubishi Chemical Corporation | Pyrimidine derivatives and anti-viral agent containing the same as active ingredient thereof |
KR0155168B1 (ko) * | 1989-09-29 | 1998-11-16 | 미우라 아끼라 | 6-치환된 아시클로피리미딘 뉴클레오시드 유도체 및 이를 활성성분으로 함유하는 항비루스제 |
US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
US5728575A (en) * | 1990-02-01 | 1998-03-17 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
US6703396B1 (en) | 1990-02-01 | 2004-03-09 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
US6642245B1 (en) | 1990-02-01 | 2003-11-04 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
CA2039039C (en) * | 1990-03-29 | 2001-05-15 | Tadashi Miyasaka | Pyrimidine nucleoside derivative and antiviral agent containing the derivative as active ingredient |
DE4020481A1 (de) * | 1990-06-27 | 1992-01-02 | Hoechst Ag | Verfahren zur herstellung von substituierten acyclischen nukleosiden und dabei auftretende zwischenprodukte |
US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
US5925643A (en) * | 1990-12-05 | 1999-07-20 | Emory University | Enantiomerically pure β-D-dioxolane-nucleosides |
US5817667A (en) * | 1991-04-17 | 1998-10-06 | University Of Georgia Research Foudation | Compounds and methods for the treatment of cancer |
US5192764A (en) * | 1991-05-30 | 1993-03-09 | Research Foundation Of State Of N.Y. | Pyrazinone n-oxide nucleosides and analogs thereof |
EP0702682B1 (de) * | 1993-06-10 | 2001-03-14 | Rolabo Sl | Verfahren zur herstellung von aminosäureester von nukleosid analogen |
NZ268479A (en) * | 1993-06-23 | 1997-07-27 | Merrell Pharma Inc | Carbo-acyclic nucleoside analogues and antiviral and antineoplastic compositions |
AU7954694A (en) | 1993-09-10 | 1995-03-27 | Centre National De La Recherche Scientifique (Cnrs) | Nucleosides with anti-hepatitis b virus activity |
US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
JPH09506333A (ja) * | 1993-09-17 | 1997-06-24 | ギリアード サイエンシーズ,インコーポレイテッド | 治療化合物の投薬方法 |
US5798340A (en) | 1993-09-17 | 1998-08-25 | Gilead Sciences, Inc. | Nucleotide analogs |
US5656745A (en) * | 1993-09-17 | 1997-08-12 | Gilead Sciences, Inc. | Nucleotide analogs |
GB9320316D0 (en) * | 1993-10-01 | 1993-11-17 | Smithkline Beecham Plc | Pharmaceuticals |
TW282470B (de) * | 1993-11-18 | 1996-08-01 | Ajinomoto Kk | |
US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
PE32296A1 (es) * | 1994-07-28 | 1996-08-07 | Hoffmann La Roche | Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables |
US5543414A (en) * | 1994-07-28 | 1996-08-06 | Syntex (Usa) Inc. | Achiral amino acid acyl esters of ganciclovir and its derivatives |
US6083953A (en) * | 1994-07-28 | 2000-07-04 | Syntex (U.S.A.) Inc. | 2- (2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3- propanediol derivative |
IL115156A (en) | 1994-09-06 | 2000-07-16 | Univ Georgia | Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines |
US5703058A (en) * | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
EP1655033A1 (de) | 1995-06-07 | 2006-05-10 | Emory University | Nucleoside mit anti-hepatitis B virus Wirksamkeit |
ES2180923T5 (es) * | 1996-01-26 | 2005-10-16 | F. Hoffmann-La Roche Ag | Proceso para la preparacion de derivados de purina. |
US5840890A (en) * | 1996-01-26 | 1998-11-24 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
AU1592897A (en) * | 1996-01-26 | 1997-08-20 | F. Hoffmann-La Roche Ag | Process for preparing purine derivatives |
US5756736A (en) * | 1996-01-26 | 1998-05-26 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
US6040446A (en) | 1996-01-26 | 2000-03-21 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative |
US5700936A (en) * | 1996-01-26 | 1997-12-23 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate |
US5869493A (en) | 1996-02-16 | 1999-02-09 | Medivir Ab | Acyclic nucleoside derivatives |
US6703394B2 (en) | 1996-02-16 | 2004-03-09 | Medivir Ab | Acyclic nucleoside derivatives |
US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
JP2001503767A (ja) * | 1996-11-12 | 2001-03-21 | メディヴィル・アクチボラグ | ヌクレオシド |
JP3844654B2 (ja) * | 1997-08-15 | 2006-11-15 | メディヴィル・アクチボラグ | レトロウイルス逆転写酵素およびb型肝炎ウイルス(hbv)のdnaポリメラーゼのインヒビターを含む抗ウイルス剤などのヌクレオシドアナログ |
WO1999051613A1 (en) * | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
US6436948B1 (en) | 2000-03-03 | 2002-08-20 | University Of Georgia Research Foundation Inc. | Method for the treatment of psoriasis and genital warts |
KR100890022B1 (ko) | 2002-07-19 | 2009-03-25 | 삼성전자주식회사 | 액정 표시 장치 및 그 구동 방법 |
TWI332507B (en) | 2002-11-19 | 2010-11-01 | Hoffmann La Roche | Antiviral nucleoside derivatives |
US20050137141A1 (en) * | 2003-10-24 | 2005-06-23 | John Hilfinger | Prodrug composition |
US20070167353A1 (en) * | 2003-10-24 | 2007-07-19 | John Hilfinger | Prodrug composition |
WO2005092891A2 (en) * | 2004-03-29 | 2005-10-06 | Ranbaxy Laboratories Limited | Preparation of esters of ganciclovir |
WO2005120577A2 (en) * | 2004-06-09 | 2005-12-22 | Ramot At Tel Aviv University Ltd. | Derivatives of chemotherapeutic agents with a formaldehyde releasing moeity |
AU2008206486C1 (en) * | 2007-01-12 | 2013-09-26 | Biomarin Pharmaceutical Inc. | Tetrahydrobiopterin prodrugs |
WO2009088530A1 (en) * | 2008-01-03 | 2009-07-16 | Biomarin Pharmaceutical Inc. | Pterin analog for treating bh4 responsive condition |
WO2011064793A1 (en) | 2009-11-24 | 2011-06-03 | Matrix Laboratories Ltd | Process for the preparation of amorphous valganciclovir hydrochloride |
US20110207931A1 (en) * | 2010-02-23 | 2011-08-25 | Srinivas Katkam | Preparation of valganciclovir and its salts |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4347360A (en) * | 1980-09-16 | 1982-08-31 | Ens Bio Logicals Inc. | Ring open nucleoside analogues |
US4868187A (en) * | 1980-09-16 | 1989-09-19 | Syntex (U.S.A.) Inc. | Anti-viral N-substituted pyrimidines |
US4355032B2 (en) * | 1981-05-21 | 1990-10-30 | 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent | |
IE54148B1 (en) * | 1981-08-11 | 1989-07-05 | Wellcome Found | Antiviral compounds |
AU564576B2 (en) * | 1981-09-24 | 1987-08-20 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Purine derivatives |
NL8202626A (nl) * | 1982-06-29 | 1984-01-16 | Stichting Rega V Z W | Derivaten van 9-(2-hydroxyethoxymethyl)guanine. |
KR890001487B1 (ko) * | 1982-10-14 | 1989-05-04 | 더 웰컴 파운데이숀 리미티드 | 푸린 유도체의 제조방법 |
JPH0625061B2 (ja) * | 1984-07-03 | 1994-04-06 | ザ ウエルカム フアウンデ−シヨン リミテツド | 抗ウイルス性化合物 |
AP160A (en) * | 1987-08-15 | 1991-11-18 | The Wellcome Foundation Ltd | Therapeutic acyclic nucleosides. |
-
1989
- 1989-12-18 DE DE2002199039 patent/DE10299039I1/de active Pending
- 1989-12-18 DE DE68922903T patent/DE68922903T2/de not_active Expired - Lifetime
- 1989-12-18 US US07/452,543 patent/US5043339A/en not_active Expired - Lifetime
- 1989-12-18 AU AU46909/89A patent/AU618436B2/en not_active Expired
- 1989-12-18 JP JP1328107A patent/JP2788084B2/ja not_active Expired - Lifetime
- 1989-12-18 CA CA002005815A patent/CA2005815C/en not_active Expired - Lifetime
- 1989-12-18 AT AT89313218T patent/ATE123285T1/de active
- 1989-12-18 EP EP89313218A patent/EP0375329B1/de not_active Expired - Lifetime
-
1997
- 1997-08-04 HK HK97101630A patent/HK1000142A1/xx not_active IP Right Cessation
-
1998
- 1998-04-30 CY CY9802058A patent/CY2058B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0375329B1 (de) | 1995-05-31 |
EP0375329A3 (de) | 1991-08-14 |
JP2788084B2 (ja) | 1998-08-20 |
AU618436B2 (en) | 1991-12-19 |
CY2058B1 (en) | 1998-04-30 |
JPH02218667A (ja) | 1990-08-31 |
US5043339A (en) | 1991-08-27 |
CA2005815C (en) | 1999-08-03 |
CA2005815A1 (en) | 1990-06-19 |
DE68922903T2 (de) | 1995-11-23 |
ATE123285T1 (de) | 1995-06-15 |
DE68922903D1 (de) | 1995-07-06 |
EP0375329A2 (de) | 1990-06-27 |
HK1000142A1 (en) | 1997-12-24 |
AU4690989A (en) | 1990-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10299039I1 (de) | Antivirale Pyrimidin- und Purinverbindungen Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Praeparte | |
MY103760A (en) | Therapeutic nucleosides | |
EP0349242A3 (de) | Therapeutische Nuleoside | |
CA2033044A1 (en) | 6-substituted purine carbocyclic nucleosides | |
BR9914097A (pt) | Composto, uso do mesmo, composição farmacêutica e método de profilaxia ou tratamento de uma infecção viral e processo para preparação do composto | |
NO2007016I1 (no) | Nelarabin eller et farmasoytisk akseptabelt salt derav (nelarabin =9- (beta-D-arabinofuranosyl-2- amino-6-metoksy-9H-purin) | |
IE892654L (en) | Therapeutic nucleosides | |
DK0479822T3 (da) | Terapeutiske nucleosider | |
EP0346108A3 (de) | Anti-infektiöse Nukleoside | |
GB8827339D0 (en) | Antiviral compounds | |
GEP19970908B (en) | Esters of 9-(2-hydroxyethoxymethyl)guanine having antiviral properties |